Business first reported 1h ago by Benzinga · updated 1h ago Immutep Reports 81.1% Disease-Free Survival Rate in Soft Tissue Sarcoma Trial Photo: Benzinga ▲ Sign in to vote stories up Coverage 1 source · 1 report Chronological. Benzinga FIRST 1h ago Immutep Reports 81.1% Disease-Free Survival Rate in Soft Tissue Sarcoma Trial Related stories Technology AI demand will push up interest rates around the world, IMF head warns 2 sources Business Palo Alto inks $4.5 billion deal for AI startup Applied Compute, shares pop 8% on earnings 3 sources Business Palo Alto stock surges as all signs point to how important cybersecurity is in the AI age 3 sources Technology California bans Waymo self-driving cars from freeways 17 sources Discussion 0 comments Sign in to join the discussion. ← Front page
Discussion 0 comments